Intraoral delivery of nicotine for smoking cessation

Details for Australian Patent Application No. 2002252685 (hide)

International Classifications

Event Publications

17 April 2003 Application Open to Public Inspection

Published as AU-B-2002252685

12 February 2004 Section 223 Application Allowed

LAVIPHARM LABORATORIES INC. The time in which to enter the National Phase has been extended to 20 Dec 2003. Address for service in Australia - Callinan Lawrie 711 High Street Kew VIC 3101

19 April 2007 Application Accepted

Published as AU-B-2002252685

31 May 2007 Application for Amendment

The nature of the amendment is as shown in the statement(s) filed 19 Apr 2007. Address for service in Australia - Callinan Lawrie Private Bag 7 KEW VIC 3101

16 August 2007 Standard Patent Sealed

18 October 2007 Amendment Made

The nature of the amendment is as shown in the statement(s) filed 19 Apr 2007

13 November 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.